散发性与MEN1相关胰腺神经内分泌肿瘤的临床特征及术后生存:国际队列研究
基于多机构国际数据库651例手术切除的胰腺神经内分泌肿瘤患者,比较MEN1相关(45例,6.9%)与散发性(606例)的临床病理特征及生存。MEN1组更年轻、多灶性及更高T分期更常见,全胰腺切除率高达5倍,但总生存与无病生存(MEN1 126个月 vs 散发198个月,P > .5)无差异,倾向评分匹配后仍相似。
要点
- MEN1相关pNET患者更年轻,多灶性和更高T分期更常见,淋巴结及转移情况相似。
- MEN1组全胰腺切除率是散发组的5倍,但术后总生存和无病生存与散发组相当。
- 即使排除行次全或全胰腺切除者,生存等效性仍持续,支持保留胰腺实质手术。
核心结论
- MEN1相关pNET与散发性pNET术后总生存和无病生存相当,即使未行根治性胰腺切除。
研究设计与样本
- 多机构国际数据库回顾性队列分析,纳入651例手术切除的pNET患者,MEN1组45例(6.9%),散发组606例,采用倾向评分匹配减少偏倚。
主要发现
- MEN1相关pNET更常见于年轻患者,手术时多灶性疾病和更高T分期更常见。
- 淋巴结受累和转移存在情况在两组间相似。
- MEN1组全胰腺切除率为散发组的5倍。
- 中位无病生存MEN1组126个月 vs 散发组198个月,P > .5;匹配后总生存两组均未达到,无病生存仍为126 vs 198个月,P > .5。
- 排除行次全和全胰腺切除的患者后,总生存和无病生存的等效性仍持续。
临床怎么用
- 对MEN1相关pNET患者应考虑保留胰腺实质的手术以保留胰腺功能,因生存与散发组相当。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The optimal surgical management of pancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 is controversial. This study sought to compare clinicopathologic characteristics and outcomes of multiple endocrine neoplasia type 1-associated and sporadic pancreatic neuroendocrine tumors from a large multi-national database. METHODS: A multi-institutional, international database of patients with surgically resected pancreatic neuroendocrine tumors was analyzed. The cohort was divided into 2 groups: those with multiple endocrine neoplasia type 1 versus those with sporadic disease. Clinicopathologic comparisons were made. Overall and disease-free survival were analyzed. Propensity score matching was used to reduce bias. RESULTS: Of 651 patients included, 45 (6.9%) had multiple endocrine neoplasia type 1 and 606 sporadic pancreatic neuroendocrine tumors. Multiple endocrine neoplasia type 1-associated pancreatic neuroendocrine tumors were more common in younger patients and associated with multifocal disease at the time of surgery and higher T-stage. Lymph node involvement and the presence of metastasis were similar. Total pancreatectomy rate was 5-fold higher in the multiple endocrine neoplasia type 1 cohort. Median survival did not differ (disease-free survival 126 months multiple endocrine neoplasia type 1 vs 198 months sporadic, P > .5). After matching, survival remained similar (overall survival not reached in either cohort, disease-free survival 126 months multiple endocrine neoplasia type 1 vs 198 months sporadic, P > .5). Equivalence in overall survival and disease-free survival persisted even when patients who underwent subtotal and total pancreatectomy were excluded. CONCLUSION: Multiple endocrine neoplasia type 1-associated pancreatic neuroendocrine tumors are more common in younger patients and are associated with multifocality and higher T-stage. Survival for patients with multiple endocrine neoplasia type 1-associated pancreatic neuroendocrine tumors is comparable to those with sporadic pancreatic neuroendocrine tumors, even in the absence of radical pancreatectomy. Consideration should be given to parenchymal-sparing surgery to preserve pancreatic function.
引用
- Bergquist JR, Shariq OA, Li AY, et al. Clinical features and postoperative survival in patients with sporadic versus multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: An international cohort study. Surgery. 2022. PMID: 35577612. doi:10.1016/j.surg.2022.04.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。